Cohort study shows an inverse association between cholesterol efflux capacity and cardiovascular events, indicating its value as a functional biomarker.
Cholesterol efflux capacity, a new biomarker that characterizes a key step in reverse cholesterol transport, was inversely associated with the incidence of cardiovascular events in a population-based cohort. (Funded by the Donald W. Reynolds Foundation and others.).
No takes yet. Share an insight, caveat, or question.
Rohatgi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: